$AQU
Aquaron Acquisition Corp.

2022 Q4 Form 10-Q Financial Statement

#000121390022073475 Filed on November 17, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2022 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $100.00
YoY Change
Gross Profit -$100.00
YoY Change
Gross Profit Margin
Selling, General & Admin $210.0K $0.00 $10.00K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $210.0K $0.00 $10.00K
YoY Change
Operating Profit -$210.1K -$121.00 -$5.027K
YoY Change
Interest Expense $440.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $220.0K $0.00 -$10.00K
YoY Change
Income Tax $50.00K
% Of Pretax Income 22.73%
Net Earnings $170.0K -$121.00 -$5.027K
YoY Change -31.64% 2874.56%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.02 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 7.040M shares 1.250M shares
Diluted Shares Outstanding 1.250M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.48M $20.00K $30.00K
YoY Change 277292.57% -60.0% -75.0%
Cash & Equivalents $57.28K $15.98K $34.51K
Short-Term Investments $55.42M
Other Short-Term Assets $220.0K $500.0K $280.0K
YoY Change -12.0% 163.16% 154.55%
Inventory
Prepaid Expenses $222.3K
Receivables
Other Receivables
Total Short-Term Assets $55.70M $510.0K $310.0K
YoY Change 20618.65% 112.5% 40.91%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $4.989K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $55.70M $510.0K $310.0K
Total Long-Term Assets $0.00 $4.989K $0.00
Total Assets $55.70M $515.0K $310.0K
YoY Change 20618.65% 114.58% 40.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0K $0.00
YoY Change 180.0%
Accrued Expenses $10.00K $201.7K
YoY Change -79.14% 908.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $300.0K $300.0K
YoY Change -100.0% 50.0% 50.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.831M $501.7K $300.0K
YoY Change 1040.29% 128.03% 50.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.831M $501.7K $300.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $2.831M $501.7K $300.0K
YoY Change 1040.29% 128.03% 50.0%
SHAREHOLDERS EQUITY
Retained Earnings $159.7K -$11.69K
YoY Change -3732.21%
Common Stock $163.00 $144.00
YoY Change 13.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 5.000M shares
Shareholders Equity $5.299M $13.31K $13.43K
YoY Change
Total Liabilities & Shareholders Equity $55.70M $515.0K $310.0K
YoY Change 20618.65% 114.58% 40.91%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income $170.0K -$121.00 -$5.027K
YoY Change -31.64% 2874.56%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$280.0K $50.00K -$60.00K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$54.98M
YoY Change
Cash From Investing Activities -$54.98M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 55.31M -60.00K -30.00K
YoY Change -184466.67% -14.29% -125.0%
NET CHANGE
Cash From Operating Activities -280.0K 50.00K -60.00K
Cash From Investing Activities -54.98M
Cash From Financing Activities 55.31M -60.00K -30.00K
Net Change In Cash 50.00K -10.00K -90.00K
YoY Change -266.67% -85.71% -175.0%
FREE CASH FLOW
Cash From Operating Activities -$280.0K $50.00K -$60.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
AQUARON ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity File Number
EntityFileNumber
001-41470
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-2760193
dei Entity Address Address Line1
EntityAddressAddressLine1
515 Madison Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
8th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
dei City Area Code
CityAreaCode
(646)
dei Local Phone Number
LocalPhoneNumber
970 2181
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001
dei Trading Symbol
TradingSymbol
AQU
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7040240 shares
CY2022Q3 us-gaap Cash
Cash
15975 usd
CY2021Q4 us-gaap Cash
Cash
16860 usd
CY2022Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
499014 usd
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
251984 usd
CY2022Q3 us-gaap Assets
Assets
514989 usd
CY2021Q4 us-gaap Assets
Assets
268844 usd
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
300 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
201676 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47940 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
300000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
200000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
501676 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
248240 usd
CY2022Q3 us-gaap Liabilities
Liabilities
501676 usd
CY2021Q4 us-gaap Liabilities
Liabilities
248240 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1437500 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1437500 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1437500 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1437500 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
144 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
144 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24856 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24856 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11687 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4396 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13313 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20604 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
514989 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
268844 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
121 usd
CY2021Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
177 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7291 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
4005 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-121 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-177 usd
us-gaap Net Income Loss
NetIncomeLoss
-7291 usd
us-gaap Net Income Loss
NetIncomeLoss
-4005 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1250000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1250000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1250000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1250000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.006
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.003
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
20604 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2143 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
18461 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5027 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13434 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-121 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13313 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3659 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-3659 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-169 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
21172 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-177 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
20995 usd
us-gaap Net Income Loss
NetIncomeLoss
-7291 usd
us-gaap Net Income Loss
NetIncomeLoss
-4005 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7291 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4005 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
100000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
93294 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
170129 usd
aqu Reimbursement Of Formation Costs Paid By Related Party
ReimbursementOfFormationCostsPaidByRelatedParty
300 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6406 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54871 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-885 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50866 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16860 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15975 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
50866 usd
aqu Deferred Offering Costs In Accrued Offering Expenses
DeferredOfferingCostsInAccruedOfferingExpenses
201676 usd
aqu Deferred Offering Costs In Accrued Offering Expenses
DeferredOfferingCostsInAccruedOfferingExpenses
18415 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
750000 shares
CY2022Q4 us-gaap Sale Leaseback Transaction Gross Proceeds Financing Activities
SaleLeasebackTransactionGrossProceedsFinancingActivities
4171800 usd
aqu Thres Hold Minimum Aggregate Fair Market Value As Percentage Of Net Assets Held In Trust Account
ThresHoldMinimumAggregateFairMarketValueAsPercentageOfNetAssetsHeldInTrustAccount
0.80 pure
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.80 pure
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5000001 usd
CY2022Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
50000 usd
aqu Trust Account Per Share
TrustAccountPerShare
10.15
CY2022Q3 us-gaap Cash
Cash
15975 usd
CY2022Q3 us-gaap Capital Units
CapitalUnits
485701 usd
us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
25000 usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
300000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.01 pure
us-gaap Effective Income Tax Rate Reconciliation Tax Credits Other
EffectiveIncomeTaxRateReconciliationTaxCreditsOther
0.01 pure
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2021Q2 aqu Aggregate Price
AggregatePrice
25000 usd
CY2021Q2 aqu Share Issued And Outstanding Percentage
ShareIssuedAndOutstandingPercentage
0.20 pure
aqu Subject To Certain Limited Exceptions Percentage
SubjectToCertainLimitedExceptionsPercentage
0.50 pure
CY2022Q3 us-gaap Cash
Cash
15975 usd
us-gaap Deferred Policy Acquisition Costs Text Block1
DeferredPolicyAcquisitionCostsTextBlock1
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Deferred Offering Costs</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Deferred offering costs consist of legal, underwriting fees and other costs incurred through the balance sheet date that are directly related to the IPO and that will be charged to stockholders’ equity upon the completion of the IPO. Should the IPO prove to be unsuccessful, these deferred costs, as well as additional expenses to be incurred, will be charged to operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentration of Credit Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts as of September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
250000 usd
us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
300000 usd
us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
750000 shares
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
750000 usd
aqu Gross Proceeds
GrossProceeds
1750000 usd
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2022Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
10000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of the common stock are entitled to one vote for each share
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1437500 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1437500 shares
us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
187500 shares
aqu Initial Stockholders Percentage
InitialStockholdersPercentage
0.20 pure
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1250000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1250000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1250000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1250000 shares
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.003
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.006
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
aqu Reimbursement Of Formation Costs Paid By Related Party
ReimbursementOfFormationCostsPaidByRelatedParty
usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001861063

Files In Submission

Name View Source Status
0001213900-22-073475-index-headers.html Edgar Link pending
0001213900-22-073475-index.html Edgar Link pending
0001213900-22-073475.txt Edgar Link pending
0001213900-22-073475-xbrl.zip Edgar Link pending
aqu-20220930.xsd Edgar Link pending
f10q0922ex31-1_aquaron.htm Edgar Link pending
f10q0922ex31-2_aquaron.htm Edgar Link pending
f10q0922ex32-1_aquaron.htm Edgar Link pending
f10q0922ex32-2_aquaron.htm Edgar Link pending
f10q0922_aquaron.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
aqu-20220930_cal.xml Edgar Link unprocessable
aqu-20220930_lab.xml Edgar Link unprocessable
aqu-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
aqu-20220930_def.xml Edgar Link unprocessable
f10q0922_aquaron_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending